Skip to main content

Daniel A. Lerner


[email protected]



Dan focuses his practice on corporate and securities law, working with public and private companies on a variety of matters.

While attending law school, Dan interned for the Honorable Gary R. Brown of the US District Court for the Eastern District of New York and the Honorable Mitchell H. Kaplan of the Massachusetts Superior Court, Business Litigation Session. Dan served as supervising editor and membership development chair of the Harvard Journal on Legislation, student attorney with the Harvard Prison Legal Assistance Project, and was a research assistant for Professor John Coates. 


This advisory discusses an August 1 amendment to the Delaware General Corporation Law that limits or eliminates monetary liability arising from breach of fiduciary duty of care lawsuits for some types of corporate officers.

Read more
This advisory discusses SEC’s amendments to the financial disclosure requirements for business acquisitions and dispositions by reporting companies and IPO candidates.
Read more
Read less

News & Press

Press Release Thumbnail

NEW YORK – Mintz represented the syndicate of underwriters led by William Blair & Company, L.L.C., in the public offering of 17,242,000 shares of common stock of Viking Therapeutics, Inc. (“Viking”) (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, at an initial offering price of $14.50 per share.

Read less